Neuberger Berman Group
SRDX

Neuberger Berman Group’s Surmodics SRDX Stock Holding History

Neuberger Berman Group’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,755
Closed -$225K – 1607
2018
Q4 		$225K Hold
4,755
– – ﹤0.01% 1462
2018
Q3 		$355K Sell
4,755
-395
-8% -$27.2K ﹤0.01% 1390
2018
Q2 		$284K Buy
+5,150
New +$238K ﹤0.01% 1536

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Neuberger Berman Group's SRDX Position: Q1 2019 in Review

Neuberger Berman Group sold out of Surmodics (SRDX) in Q1 2019, closing a stake of 4,755 shares — an estimated $225K sold.

Neuberger Berman Group first reported a position in SRDX in Q2 2018 and held it in 3 quarters. The position peaked at $355K in Q3 2018. 151 funds tracked by Wall St. Rank hold SRDX as of Q1 2019.

  • Neuberger Berman Group reported no remaining Surmodics position as of Q1 2019 after selling out during the quarter.
  • Neuberger Berman Group sold 4,755 Surmodics shares in Q1 2019, an estimated $225K.
  • Neuberger Berman Group first reported a position in Surmodics in Q2 2018 and held it in 3 quarters.
  • Neuberger Berman Group's Surmodics position peaked at $355K in Q3 2018.
  • 151 funds tracked by Wall St. Rank held Surmodics as of Q1 2019.

Based on Neuberger Berman Group's 13F filing for Q1 2019, filed 13 May 2019.